Texas Institute for Kidney and Endocrine Disorders — Lufkin, Texas

Texas Institute for Kidney and Endocrine Disorders is a clinical research site located in Lufkin, Texas, United States 75904.

Crixeo Clinical Trials Trust Score: 18/100 (FAILING). This profile has not yet been claimed by the site owner.

Texas Institute for Kidney and Endocrine Disorders has participated in 9 clinical trials with 3 currently active.

Therapeutic areas: Kidney Disease, Chronic, Diabetic Nephropathies, Atherosclerotic Cardiovascular Disease (ASCVD).

Sponsors: Boehringer Ingelheim, Eli Lilly and Company, Amgen.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Lufkin

Browse all research sites in Texas · View every site in Lufkin

Sponsor Feasibility Report

Trust Score: 18/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Texas Institute for Kidney and Endocrine Disorders?

Texas Institute for Kidney and Endocrine Disorders has a Crixeo Trust Score of 18/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Texas Institute for Kidney and Endocrine Disorders conducted?

Texas Institute for Kidney and Endocrine Disorders has 9 clinical trials on record, with 3 currently active. Their work covers Kidney Disease, Chronic, Diabetic Nephropathies, Atherosclerotic Cardiovascular Disease (ASCVD).

Is Texas Institute for Kidney and Endocrine Disorders accredited by Crixeo Clinical Trials?

Texas Institute for Kidney and Endocrine Disorders has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Texas Institute for Kidney and Endocrine Disorders?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.